Congestive Heart Failure and Central Sleep Apnea
نویسندگان
چکیده
منابع مشابه
Sleep apnea and heart failure: Part II: central sleep apnea.
In the first part of this 2-part review, we provided a synopsis of the cardiovascular effects of normal sleep and an overview of the diagnostic, pathophysiological, and therapeutic implications of obstructive sleep apnea (OSA) in the setting of heart failure (HF). In this second part, we turn our attention to central sleep apnea (CSA), commonly referred to as Cheyne-Stokes respiration. This bre...
متن کاملBrain natriuretic peptide in patients with congestive heart failure and central sleep apnea.
STUDY OBJECTIVE To assess the possible relationship between Cheyne-Stokes respiration (CSR) associated with central sleep apnea (CSA) syndrome and brain natriuretic peptide (BNP) in an outpatient population presenting with stable congestive heart failure (CHF). MEASUREMENTS AND RESULTS Ninety patients with CHF due to systolic dysfunction (left ventricular ejection fraction <or= 45%) were pros...
متن کاملCPAP should not be used for central sleep apnea in congestive heart failure patients.
399 B oth sleep apnea and congestive heart failure are common disorders. However, systolic heart failure appears to be the most common cause of central and perhaps obstructive sleep apnea. Obstructive sleep apnea is also common in isolated diastolic heart failure and may contribute to the progression of left ventricular remodeling and perhaps play a causative role. 1,3-6 However, prevalence and...
متن کاملHeart Failure and Central Sleep Apnea/ Cheyne-Stokes Respiration
1 Sin et al. American Journal of Respiratory Critical Care Medicine; 1999 2 Lafranchi et al. Circulation; 1999 3 Philippe et al. Heart; 2005 4 Javaheri et al. Circulation; 1998 5 Sin et al. American Journal of Respiratory Critical Care Medicine; 1999 Sleep-disordered breathing (SDB) is recognized as a serious health problem that impacts the cardiovascular system. Clinical studies have shown the...
متن کاملSleep Apnea and Heart Failure
Heart failure (HF) affects 5 to 6 million North Americans and is increasing in prevalence.1 Mortality remains high. In Ontario, for example, between 1994 and 1997, approximately 33% of patients diagnosed with HF on first admission to hospital died within 1 year.2 Reductions in mortality demonstrated in randomized clinical trials of pharmacological agents, such as -receptor blockers3 and angiote...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Critical Care Clinics
سال: 2015
ISSN: 0749-0704
DOI: 10.1016/j.ccc.2015.03.005